A7 (P246)Medway NHS foundation trust: Variable rate intravenous insulin infusion mandatory training implementationA EPPS and R WattDiabetes Centre, Medway NHS Foundation Trust, Gillingham, UKBackground and aimVariable rate intravenous insulin infusion (VRIII) is used in an inpatient setting to achieve glycaemic control.The National Adult Diabetes Inpatient Audit 2016 highlights the following7.1% of insulin infusions were considered inappropriate.6.1% exceeded acceptable duration.14% the transfer to subcutaneous insulin was incorrectly managed.There are several complications associated with VRIII includingHyponatraemiaHypo/hyperkalaemiaFluid overloadHypoglycaemiaHyperglycaemiaDKAMorbidityOur aim was to reduce harm caused by VRIII in a hospital setting.Method: We implemented a mandatory competency in VRIII for all staff who wished to use the device. Implementation of training included face to face sessions, attendance of ward meetings and handovers and an e‐learning module.Results and conclusionIntroducing the mandatory competency led to a 50% reduction in associated errors reported via the Datix system for the same three‐month period in 2016 (June–August). Out of 30 Datix received in the total 15‐month study period, 29 incidents involved staff who were not trained. Only one incident involved a member of staff who had completed the training. Further research using freedom of information data involving 84 NHS trusts found that only 16 trusts had mandatory VRIII training
Diabetic Medicine – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera